Increase in MR-proADM after one year was associated with increased risk of subsequent CHD events ( HR @ , @-@ @ ) , non-fatal myocardial infarction ( HR @ , @-@ @ ) , heart failure ( HR @ , @-@ @ ) and all-cause mortality ( HR @ , @-@ @ ) .